Logo-aim
Arch Iran Med. 2019;22(5): 236-241.
PMID: 31256595
Scopus ID: 85068688738
  Abstract View: 3295
  PDF Download: 1538

Original Article

Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?

Osman Köstek 1*, Yakup Bozkaya 2, Muhammet Bekir Hacıoğlu 1, Nuriye Yıldırım Özdemir 2, Erdem Yılmaz 3, Nazım Can Demircan 2, Bulent Erdoğan 1, Sernaz Uzunoğlu 1, İrfan Çiçin 1, Nurullah Zengin 2

1 Department of Internal Medicine, Divison of Medical Oncology, Trakya University, Edirne, Turkey
2 Ankara Numune Training and Research Hospital, Clinic of Medical Oncology, Ankara, Turkey
3 Department of Internal Radiology, Trakya University, Edirne, Turkey
*Corresponding Author: Email: osmankostek@hotmail.com

Abstract

Background: Aging is significantly related to multiple comorbidities. Even with a good performance score, some elderly patients may have poor survival outcomes. We aimed to evaluate the prognostic value of the Charlson comorbidity index (CCI) for mortality and toxicity in elderly patients with locally advanced rectal cancer (LARC).

Methods: Seventy-two elderly patients with LARC who were treated with neoadjuvant chemoradiotherapy (CRT) were included. Based on their CCI score, severity of the comorbidity was categorized into 2 groups: CCI<7 and CCI≥7.

Results: The overall survival (OS) at 5 years was 54.4 percent in patients treated with neoadjuvant CRT. Median OS was not reached for all patients as well as patients with CCI score <7, but median OS was 25 (95% CI 1.0–62.1) months in patients with CCI≥7 (P=0.002). The OS at 2 years was 79.1 percent in the patients with CCI <7 and 50.0 percent in the patients with CCI score ≥7 (P=0.002). Moreover, there was a trend toward, patients with higher CCI score who had more treatment related to grade 3 or 4 toxicity compared to those with CCI score <7 (33.3% vs 13.3%, respectively, P=0.09). Multivariable analysis indicated that the CCI score ≥7, presence of down-staging after therapy and clinical stage (III) independently predict mortality (HR 6.14, 95%CI 2.45–15.35, P<0.001) in patients with LARC .

Conclusion: Although CCI score was not significantly associated with both toxicity and disease-free survival (DFS), we suggest that baseline CCI score might be a valuable prognostic indicator for physicians to evaluate elderly patiens with LARC for optimal treatment.


Cite this article as: Köstek O, Bozkaya Y, Hacıoğlu MB, Özdemir NY, Yılmaz E, Demircan NC, et al. Is the Charlson comorbidity ındex a prognostic ındicator for toxicity and mortality in elderly patients with locally advanced rectal cancer? Arch Iran Med. 2019;22(5):236–241.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 3296

Your browser does not support the canvas element.


PDF Download: 1538

Your browser does not support the canvas element.

Submitted: 05 Jun 2018
Accepted: 07 Apr 2019
ePublished: 01 May 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)